Complex networks reveal early MRI markers of Parkinson's disease

Med Image Anal. 2018 Aug;48:12-24. doi: 10.1016/j.media.2018.05.004. Epub 2018 May 17.

Abstract

Parkinson's disease (PD) is the most common neurological disorder, after Alzheimer's disease, and is characterized by a long prodromal stage lasting up to 20 years. As age is a prominent factor risk for the disease, next years will see a continuous increment of PD patients, making urgent the development of efficient strategies for early diagnosis and treatments. We propose here a novel approach based on complex networks for accurate early diagnoses using magnetic resonance imaging (MRI) data; our approach also allows us to investigate which are the brain regions mostly affected by the disease. First of all, we define a network model of brain regions and associate to each region proper connectivity measures. Thus, each brain is represented through a feature vector encoding the local relationships brain regions interweave. Then, Random Forests are used for feature selection and learning a compact representation. Finally, we use a Support Vector Machine to combine complex network features with clinical scores typical of PD prodromal phase and provide a diagnostic index. We evaluated the classification performance on the Parkinson's Progression Markers Initiative (PPMI) database, including a mixed cohort of 169 normal controls (NC) and 374 PD patients. Our model compares favorably with existing state-of-the-art MRI approaches. Besides, as a difference with previous approaches, our methodology ranks the brain regions according to disease effects without any a priori assumption.

Keywords: Complex networks; MRI; Machine learning; Parkinson’s disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Algorithms
  • Biomarkers / analysis
  • Disease Progression
  • Early Diagnosis
  • Female
  • Humans
  • Image Interpretation, Computer-Assisted / methods*
  • Magnetic Resonance Imaging / methods*
  • Male
  • Middle Aged
  • Parkinson Disease / diagnostic imaging*
  • Support Vector Machine

Substances

  • Biomarkers